|The largest selection of target-based binding and functional assays for assessing compound potency & selectivity
||A systems based approach to screen for compound potency & liability as well as related predictive biomarkers using human cell models of oncology, immunology and cellular toxicity.
||Disease relevant in vivo models to evaluate drug candidate efficacy in all major therapeutic areas (emphasizing anti-infectives, inflammation, CNS/pain and oncology) and early PK and toxicity assessment.
|A comprehensive offering of nonclinical ADME PK and toxicology assays to assess drug metabolism and safety properties early in the discovery process
||Customized protein production, cell line and assay development using a diverse set of platforms and technologies
||Instant access to reports and analytic data